Sharib, J., Rhodin, K. E., Liu, A., McIntyre, S., Bartholomew, A., Masoud, S., … Lidsky, M. E. (2025). ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol, 32(4), 2501–2502. https://doi.org/10.1245/s10434-025-16881-1

Sharib, Jeremy, Kristen E. Rhodin, Annie Liu, Sarah McIntyre, Alex Bartholomew, Sabran Masoud, Isabel DeLaura, et al. “ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.” Ann Surg Oncol 32, no. 4 (April 2025): 2501–2. https://doi.org/10.1245/s10434-025-16881-1.

Sharib J, Rhodin KE, Liu A, McIntyre S, Bartholomew A, Masoud S, et al. ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2025 Apr;32(4):2501–2.

Sharib, Jeremy, et al. “ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.” Ann Surg Oncol, vol. 32, no. 4, Apr. 2025, pp. 2501–02. Pubmed, doi:10.1245/s10434-025-16881-1.

Sharib J, Rhodin KE, Liu A, McIntyre S, Bartholomew A, Masoud S, DeLaura I, Kemeny NE, Cercek A, Harding JJ, O’Reilly EM, Abou-Alfa GK, Reidy-Lagunes D, Connell LC, El Dika I, Balachandran VP, Drebin J, Soares KC, Wei AC, Kingham TP, D’Angelica MI, Uronis H, Strickler J, Hsu SD, Morse M, Zani S, Allen PJ, Jarnagin WR, Lidsky ME. ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2025 Apr;32(4):2501–2502.